ATE81016T1 - Anwendung heterozyklischer dervate zur herstellung von arzneimitteln. - Google Patents

Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.

Info

Publication number
ATE81016T1
ATE81016T1 AT87311080T AT87311080T ATE81016T1 AT E81016 T1 ATE81016 T1 AT E81016T1 AT 87311080 T AT87311080 T AT 87311080T AT 87311080 T AT87311080 T AT 87311080T AT E81016 T1 ATE81016 T1 AT E81016T1
Authority
AT
Austria
Prior art keywords
dervatives
pharmaceuticals
heterocyclic
production
application
Prior art date
Application number
AT87311080T
Other languages
English (en)
Inventor
Michael Brian Tyers
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE81016T1 publication Critical patent/ATE81016T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT87311080T 1986-12-17 1987-12-16 Anwendung heterozyklischer dervate zur herstellung von arzneimitteln. ATE81016T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868630079A GB8630079D0 (en) 1986-12-17 1986-12-17 Medicaments
EP87311080A EP0275669B1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer Dervate zur Herstellung von Arzneimitteln

Publications (1)

Publication Number Publication Date
ATE81016T1 true ATE81016T1 (de) 1992-10-15

Family

ID=10609120

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87311080T ATE81016T1 (de) 1986-12-17 1987-12-16 Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.

Country Status (5)

Country Link
EP (1) EP0275669B1 (de)
JP (1) JPS63277635A (de)
AT (1) ATE81016T1 (de)
DE (1) DE3782030T2 (de)
GB (1) GB8630079D0 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
KR20060118421A (ko) * 2003-08-29 2006-11-23 다이노젠 파마세우티컬스, 인코포레이티드 위장 운동 장애의 치료에 유용한 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920003064B1 (ko) * 1984-01-25 1992-04-13 글락소 그룹 리미티드 헤테로시클릭 화합물의 제조방법
GB8516083D0 (en) * 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
EP0275669A1 (de) 1988-07-27
JPS63277635A (ja) 1988-11-15
EP0275669B1 (de) 1992-09-30
GB8630079D0 (en) 1987-01-28
DE3782030T2 (de) 1993-02-18
DE3782030D1 (de) 1992-11-05

Similar Documents

Publication Publication Date Title
NO176049C (no) Analogifremgangsmåte for fremstilling av terapeutiske imidazoler som blokkerer angiotensin-II-reseptorer
ATE45942T1 (de) Diarylacetylene, ihre herstellung und verwendung.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
DE3752062D1 (de) Verwendung von heterozyklischen Derivaten zur Herstellung von Arzneimitteln
FR2617041B1 (fr) Orthese ou prothese pour la coordination des mouvements
NO872589D0 (no) Noeytrale metalloendopeptidaseinhibitorer for behandling av hypertensjon.
DE3785602D1 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE69530933D1 (de) Verwendung von 5-(tetradecyloxy)-2-furan carbonsäure für die behandlung von alzheimer krankheit oder psychosis
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
FI905481A0 (fi) Substituerade n-(imidazolyl) -alkylalaninderivat.
SE8503207L (sv) Farmakologiskt aktiva substituerade bensamider
ATE95704T1 (de) Anwendung heterozyklischer derivate zur herstellung von arzneimitteln.
ATE79257T1 (de) Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
ATE182467T1 (de) Verwendung von antagonisten oder partiellen agonisten am 5-ht 1a-rezeptor zur behandlung und prävention von kognitiven störungen
ATE81016T1 (de) Anwendung heterozyklischer dervate zur herstellung von arzneimitteln.
DE69420679D1 (de) Verwendung der 1-4-4-Aryl(oder Heteroaryl)-1-Piperazinylbutyl-1H-Azol-Derivate zur Herstellung von Arzneimitteln zur Behandlung der Störungen der Magensekretion
ATE123942T1 (de) 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung als antikonvulsiva.
DE58905133D1 (de) Verwendung eines goldbades zur herstellung von zahnersatz.
FR2544614B1 (fr) Nouvelle association medicamenteuse pour le traitement de l'hypertension
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
ATE22010T1 (de) Antipsychotische trans-dihydrolisuride.
DE68926222D1 (de) Verwendung von 1,2,3,4-Tetrahydroacridinen zur Behandlung von AIDS, sowie Verbindungen
AT388731B (de) Neue derivate von benzimidazol, ihre herstellung und verwendung
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68910444D1 (de) 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties